Trabectedin
| CAS No. | 114899-77-3 |
|---|---|
| MDL No. | N/A |
| MF | C39H43N3O11S |
| MW | 761.80 |
| InChI Key | PKVRCIRHQMSYJX-AIFWHQITSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Trabectedin is a tetrahydroisoquinoline alkaloid derived from the Caribbean tunicate Ecteinascidia turbinata. It is used to treat soft tissue sarcoma and relapsed ovarian cancer. Trabectedin functions as an antineoplastic agent, marine metabolite, anti-inflammatory agent, angiogenesis modulator, and alkylating agent. Structurally, it is an organic heteropolycyclic compound, featuring azaspiro, oxaspiro, and bridged frameworks, and contains lactone, polyphenol, acetate ester, hemiaminal, sulfide, tertiary amine, and isoquinoline functionalities.
| CAS No. | 114899-77-3 |
|---|---|
| Product Name | Trabectedin |
Associated Conditions
mesothelioma·ovarian neoplasm·neoplasm·lymphoid leukemia·peritoneum cancer·
* The information provided here is compiled from public sources and is for reference only.
